Cell and Gene Therapy Bioprocessing (MBI® Training, Bioprocess Industries)
Course
In London
Description
-
Type
Course
-
Level
Intermediate
-
Location
London
-
Class hours
18h
-
Duration
3 Days
Cell and gene therapy is an emerging field that aims to utilise the power of cell-based medicines, including regenerative medicine, to deliver new treatments.
This three-day course addresses the challenges of translating scientific discoveries into medicinal products in a way that is commercially viable.
It's aimed at engineers, life scientists and clinicians working in regenerative medicine and cell and gene therapy.
Facilities
Location
Start date
Start date
About this course
By attending an MBI® course, you'll:
benefit from knowledge transfer and upskilling in core bioprocessing fundamentals and trends in industry
gain a deeper understanding of process options and engineering constraints
acquire the tools to optimise process performance and economics
learn about the latest technical and regulatory developments
have access to cutting edge research methodologies
network with sector leaders and subject matter experts
increase your flexibility, motivation, creativity and professional status
This course is for engineers, life scientists and clinicians working in the fields of regenerative medicine and cell and gene therapy.
It also provides a strong fundamental base for life scientists and engineers from biopharma who wish to re-purpose skills for the cell and gene therapy sector.
Reviews
This centre's achievements
All courses are up to date
The average rating is higher than 3.7
More than 50 reviews in the last 12 months
This centre has featured on Emagister for 14 years
Subjects
- Scaling up lentivirus
- Gene products
- Monitoring
- Navigating
- CoGs
- Process economics
- Economics
- Manufacturing scale up
- Analytic tools
- Engineering
Course programme
The course involves lectures by leading academic and industry experts and interactive case studies.
Topics covered include:
- Challenges for scaling up lentivirus
- Taking cell and gene products from lab to clinic in the real world
- Process considerations for universal versus personalised therapies
- Analytics and monitoring where the cell is the product
- A role for automation
- Navigating the critical path to clinic
- Addressing process economics and CoGs
Case studies will include:
- Manufacturing scale up
- Process and product analytic tools
Cell and Gene Therapy Bioprocessing (MBI® Training, Bioprocess Industries)